EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications

Paschalis Karakasis iD, Panagiotis Theofilis iD, Eleftheria Lefkou, Antonios P Antoniadis, Dimitrios Patoulias iD, Panagiotis Korantzopoulos iD, Nikolaos Fragakis iD

International Journal of Molecular Sciences · 18.03.2025 · 26 (6) · 2739

DOI: 10.3390/ijms26062739 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.03.2025. Verfasst von Paschalis Karakasis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiology, Hippokration General Hospital, Medical School, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Th…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Clonal Hematopoiesis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal hematopoiesis of indeterminate potential (CHIP) has emerged as a novel risk factor for cardiovascular diseases. CHIP is characterized by the expansion of hematopoietic stem cell clones harboring somatic mutations in genes such as TET2, DNMT3A, and ASXL1, which are implicated in inflammation, atrial remodeling, and hypercoagulability. These mutations foster a pro-inflammatory and pro-thrombotic environment conducive to arrhythmogenesis, thereby linking CHIP to the development and progression of atrial fibrillation (AF). Mechanistic insights indicate that CHIP contributes to atrial fibrosis, disrupts calcium signaling, and exacerbates oxidative stress, all of which heighten susceptibility to AF. Clinical studies, including epidemiological and Mendelian randomization analyses, further support the association between CHIP and an increased risk of both incident and progressive AF, with specific mutations such as TET2 and ASXL1 identified as significant contributors. Additionally, CHIP has been linked to adverse outcomes in AF, including elevated rates of heart failure, thromboembolism, and mortality. Understanding CHIP’s role in AF pathophysiology offers opportunities for the development of precision medicine approaches, providing novel avenues for early intervention and targeted AF treatment. This review synthesizes current mechanistic and clinical evidence on the role of CHIP in AF, emphasizes its potential as a biomarker for risk stratification, and explores emerging therapeutic strategies targeting CHIP-associated pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationClonal HematopoiesisHumansMutationDioxygenasesAnimalsDNA Methyltransferase 3ARepressor ProteinsDNA-Binding ProteinsProto-Oncogene ProteinsDNA (Cytosine-5-)-Methyltransferases

Stichwörter der Autor:innen

ASXL1DNMT3ATET2atrial fibrillationatrial fibrosisclonal hematopoiesis of indeterminate potentialinflammation

Substanzen

TET2 protein, humanASXL1 protein, humanDioxygenasesDNA Methyltransferase 3ARepressor ProteinsDNA-Binding ProteinsProto-Oncogene ProteinsDNA (Cytosine-5-)-MethyltransferasesDNMT3A protein, human

Autor:innen und Institutionen

  • Second Department of Cardiology, Hippokration General Hospital, Medical School, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
  • First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Perigenesis, Institute of Obstetric Haematology, 54623 Thessaloniki, Greece.
  • Second Propedeutic Department of Internal Medicine, Faculty of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
  • First Department of Cardiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45500 Ioannina, Greece.

ORCID-Profile: Paschalis Karakasis, Panagiotis Theofilis, Dimitrios Patoulias, Panagiotis Korantzopoulos, Nikolaos Fragakis

Zitieren

APA

Karakasis, P., Theofilis, P., Lefkou, E., Antoniadis, A. P., Patoulias, D., Korantzopoulos, P., & Fragakis, N. (2025). Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications. International Journal of Molecular Sciences, 26(6), 2739. https://doi.org/10.3390/ijms26062739

Vancouver

Karakasis P, Theofilis P, Lefkou E, Antoniadis AP, Patoulias D, Korantzopoulos P, et al. Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications. International Journal of Molecular Sciences. 2025;26(6):2739. doi:10.3390/ijms26062739

BibTeX
@article{Karakasis2025,
  author = {Karakasis, Paschalis and Theofilis, Panagiotis and Lefkou, Eleftheria and Antoniadis, Antonios P and Patoulias, Dimitrios and Korantzopoulos, Panagiotis and Fragakis, Nikolaos},
  title = {Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {6},
  pages = {2739},
  doi = {10.3390/ijms26062739}
}
Kostenlos starten →